Case study: India's billion dollar biotech

Nature Biotechnology

Volumn 28, Issue 8, 2010, Pages 783-

  Chakma, Justin ^a   Masum, Hassan ^a   Perampaladas, Kumar ^a   Heys, Jennifer ^a   Singer, Peter A ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

BIOTECHNOLOGY; COST BENEFIT ANALYSIS; INDIA; MERGERS AND ACQUISITIONS; NOTE; PRIORITY JOURNAL; VACCINE PRODUCTION;

BIOTECHNOLOGY; HUMANS; INDIA; INTERNATIONAL COOPERATION; INVESTMENTS; MODELS, ECONOMIC; OUTSOURCED SERVICES; PHARMACEUTICAL PREPARATIONS; RESEARCH SUPPORT AS TOPIC;

EID: 77955450696     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0810-783     Document Type: Note

References (1)

1. Prahalad, CK. The Fortune at the Bottom of the Pyramid: Eradicating Poverty through Profits. (Wharton School Publishing, Philadelphia; 2004).